The Latin America, Middle East and Africa Large Molecule Drug Substance CDMO Market would witness market growth of 11.0% CAGR during the forecast period (2022-2028).
The development of CDMOs is being driven by their assistance in meeting deadlines and overcoming difficulties, like the fragility of the large molecule-based active compounds, in the early drug development stages. Numerous innovative techniques have been developed that combat the fragility and complexity issues of large molecules.
For example, techniques like encapsulation and buffer use work by promoting the stabilization of large molecules, thereby protecting them. The rising elderly population, worldwide growth of economy, and new product launches are propelling the growth of the pharmaceutical industry and CDMOs exponentially.
Similarly, the increasing preference for gene and cell therapies are advancing the growth of the biologics. This growth further perpetuates its positive effect on the originator biologics as well. One of the major drivers that are influencing the growth of biologics is the rising cancer therapies demand. As a result, there has been a steady increase in the number of large molecules being approved.
In this region, the healthcare industry has significantly grown and has become one of the GCC's most important sectors for promoting economic diversification. Consequently, public-private partnerships are being encouraged, and private businesses are compelled to build infrastructure for further developing the drug manufacturing processes. In addition, the increasing preference for preventive care over curative care by the younger, healthier population is pushing the sector positively.
The Brazil market dominated the LAMEA Large Molecule Drug Substance CDMO Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $295 million by 2028. The Argentina market is experiencing a CAGR of 11.6% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 10.7% during (2022 - 2028).
Based on Application, the market is segmented into Mammalian, Microbial and Others. Based on Service, the market is segmented into Contract Manufacturing and Contract Development. Based on Contract Manufacturing Type, the market is segmented into Commercial and Clinical. Based on Contract Development Type, the market is segmented into Cell Line Development and Process Development. Based on End-user, the market is segmented into Biotech Companies, CRO and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Large Molecule Drug Substance CDMO Market is Predict to reach $19.2 Billion by 2028, at a CAGR of 8.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eurofins Scientific SE, WuXi Biologics (Cayman), Inc, Catalent, Inc., Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies Texas LLC (Fujifilm Corporation), Samsung Biologics Co., Ltd. (Samsung Group), Rentschler Biopharma SE, AGC Biologics, Inc. (AGC, Inc.), Recipharm AB (EQT AB), and Siegfried Holding AG.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Mammalian
- Microbial
- Others
By Service
- Contract Manufacturing
- Contract Development
- Cell Line Development
- Process Development
By End-user
- Biotech Companies
- CRO
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Eurofins Scientific SE
- WuXi Biologics (Cayman), Inc
- Catalent, Inc.
- Boehringer Ingelheim International GmbH
- FUJIFILM Diosynth Biotechnologies Texas LLC (Fujifilm Corporation)
- Samsung Biologics Co., Ltd. (Samsung Group)
- Rentschler Biopharma SE
- AGC Biologics, Inc. (AGC, Inc.)
- Recipharm AB (EQT AB)
- Siegfried Holding AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Large Molecule Drug Substance CDMO Market, by Application
1.4.2 LAMEA Large Molecule Drug Substance CDMO Market, by Service
1.4.3 LAMEA Large Molecule Drug Substance CDMO Market, by End-user
1.4.4 LAMEA Large Molecule Drug Substance CDMO Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Apr– 2022, Oct) Leading Players
3.3.3 Key Strategic Move: (Acquisitions and Mergers : 2018, Oct – 2022, Aug) Leading Players
Chapter 4. LAMEA Large Molecule Drug Substance CDMO Market by Application
4.1 LAMEA Mammalian Market by Country
4.2 LAMEA Microbial Market by Country
4.3 LAMEA Other Application Market by Country
Chapter 5. LAMEA Large Molecule Drug Substance CDMO Market by Service
5.1 LAMEA Contract Manufacturing Market by Country
5.2 LAMEA Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
5.2.1 LAMEA Commercial Market by Country
5.2.2 LAMEA Clinical Market by Country
5.3 LAMEA Contract Development Market by Country
5.4 LAMEA Large Molecule Drug Substance CDMO Market by Contract Development Type
5.4.1 LAMEA Cell Line Development Market by Country
5.4.2 LAMEA Process Development Market by Country
Chapter 6. LAMEA Large Molecule Drug Substance CDMO Market by End-user
6.1 LAMEA Biotech Companies Market by Country
6.2 LAMEA CRO Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Large Molecule Drug Substance CDMO Market by Country
7.1 Brazil Large Molecule Drug Substance CDMO Market
7.1.1 Brazil Large Molecule Drug Substance CDMO Market by Application
7.1.2 Brazil Large Molecule Drug Substance CDMO Market by Service
7.1.2.1 Brazil Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.1.2.2 Brazil Large Molecule Drug Substance CDMO Market by Contract Development Type
7.1.3 Brazil Large Molecule Drug Substance CDMO Market by End-user
7.2 Argentina Large Molecule Drug Substance CDMO Market
7.2.1 Argentina Large Molecule Drug Substance CDMO Market by Application
7.2.2 Argentina Large Molecule Drug Substance CDMO Market by Service
7.2.2.1 Argentina Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.2.2.2 Argentina Large Molecule Drug Substance CDMO Market by Contract Development Type
7.2.3 Argentina Large Molecule Drug Substance CDMO Market by End-user
7.3 UAE Large Molecule Drug Substance CDMO Market
7.3.1 UAE Large Molecule Drug Substance CDMO Market by Application
7.3.2 UAE Large Molecule Drug Substance CDMO Market by Service
7.3.2.1 UAE Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.3.2.2 UAE Large Molecule Drug Substance CDMO Market by Contract Development Type
7.3.3 UAE Large Molecule Drug Substance CDMO Market by End-user
7.4 Saudi Arabia Large Molecule Drug Substance CDMO Market
7.4.1 Saudi Arabia Large Molecule Drug Substance CDMO Market by Application
7.4.2 Saudi Arabia Large Molecule Drug Substance CDMO Market by Service
7.4.2.1 Saudi Arabia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.4.2.2 Saudi Arabia Large Molecule Drug Substance CDMO Market by Contract Development Type
7.4.3 Saudi Arabia Large Molecule Drug Substance CDMO Market by End-user
7.5 South Africa Large Molecule Drug Substance CDMO Market
7.5.1 South Africa Large Molecule Drug Substance CDMO Market by Application
7.5.2 South Africa Large Molecule Drug Substance CDMO Market by Service
7.5.2.1 South Africa Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.5.2.2 South Africa Large Molecule Drug Substance CDMO Market by Contract Development Type
7.5.3 South Africa Large Molecule Drug Substance CDMO Market by End-user
7.6 Nigeria Large Molecule Drug Substance CDMO Market
7.6.1 Nigeria Large Molecule Drug Substance CDMO Market by Application
7.6.2 Nigeria Large Molecule Drug Substance CDMO Market by Service
7.6.2.1 Nigeria Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.6.2.2 Nigeria Large Molecule Drug Substance CDMO Market by Contract Development Type
7.6.3 Nigeria Large Molecule Drug Substance CDMO Market by End-user
7.7 Rest of LAMEA Large Molecule Drug Substance CDMO Market
7.7.1 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Application
7.7.2 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Service
7.7.2.1 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.7.2.2 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Contract Development Type
7.7.3 Rest of LAMEA Large Molecule Drug Substance CDMO Market by End-user
Chapter 8. Company Profiles
8.1 Teledyne FLIR LLC (Teledyne Technologies Incorporated)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.1.5 SWOT Analysis
8.2 Hikvision Digital Technology Co., Ltd., (China Electronics Technology Group Corporation)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.3 Axis Communications AB (Canon, Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Bosch Security Systems GmbH (Robert Bosch GmbH)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Avigilon Corporation (Motorola Solutions)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.6 Hanwha Techwin Co., Ltd. (Hanwha Group)
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Product Launches and Product Expansions:
8.7 Zhejiang Dahua Technology Co., Ltd.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Zhejiang Uniview Technologies Co., Ltd. (Hangzhou Jiaozhi Technology Co., Ltd.)
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 LAMEA Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Large Molecule Drug Substance CDMO Market
TABLE 4 Acquisition and Mergers– Large Molecule Drug Substance CDMO Market
TABLE 5 Geographical Expansions – Large Molecule Drug Substance CDMO Market
TABLE 6 LAMEA Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 7 LAMEA Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 8 LAMEA Mammalian Market by Country, 2018 - 2021, USD Million
TABLE 9 LAMEA Mammalian Market by Country, 2022 - 2028, USD Million
TABLE 10 LAMEA Microbial Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Microbial Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA Other Application Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA Other Application Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 15 LAMEA Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 16 LAMEA Contract Manufacturing Market by Country, 2018 - 2021, USD Million
TABLE 17 LAMEA Contract Manufacturing Market by Country, 2022 - 2028, USD Million
TABLE 18 LAMEA Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 19 LAMEA Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 20 LAMEA Commercial Market by Country, 2018 - 2021, USD Million
TABLE 21 LAMEA Commercial Market by Country, 2022 - 2028, USD Million
TABLE 22 LAMEA Clinical Market by Country, 2018 - 2021, USD Million
TABLE 23 LAMEA Clinical Market by Country, 2022 - 2028, USD Million
TABLE 24 LAMEA Contract Development Market by Country, 2018 - 2021, USD Million
TABLE 25 LAMEA Contract Development Market by Country, 2022 - 2028, USD Million
TABLE 26 LAMEA Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 27 LAMEA Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 28 LAMEA Cell Line Development Market by Country, 2018 - 2021, USD Million
TABLE 29 LAMEA Cell Line Development Market by Country, 2022 - 2028, USD Million
TABLE 30 LAMEA Process Development Market by Country, 2018 - 2021, USD Million
TABLE 31 LAMEA Process Development Market by Country, 2022 - 2028, USD Million
TABLE 32 LAMEA Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 33 LAMEA Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 34 LAMEA Biotech Companies Market by Country, 2018 - 2021, USD Million
TABLE 35 LAMEA Biotech Companies Market by Country, 2022 - 2028, USD Million
TABLE 36 LAMEA CRO Market by Country, 2018 - 2021, USD Million
TABLE 37 LAMEA CRO Market by Country, 2022 - 2028, USD Million
TABLE 38 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 39 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 40 LAMEA Large Molecule Drug Substance CDMO Market by Country, 2018 - 2021, USD Million
TABLE 41 LAMEA Large Molecule Drug Substance CDMO Market by Country, 2022 - 2028, USD Million
TABLE 42 Brazil Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 43 Brazil Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 44 Brazil Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 45 Brazil Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 46 Brazil Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 47 Brazil Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 48 Brazil Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 49 Brazil Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 50 Brazil Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 51 Brazil Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 52 Brazil Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 53 Brazil Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 54 Argentina Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 55 Argentina Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 56 Argentina Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 57 Argentina Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 58 Argentina Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 59 Argentina Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 60 Argentina Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 61 Argentina Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 62 Argentina Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 63 Argentina Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 64 Argentina Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 65 Argentina Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 66 UAE Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 67 UAE Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 68 UAE Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 69 UAE Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 70 UAE Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 71 UAE Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 72 UAE Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 73 UAE Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 74 UAE Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 75 UAE Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 76 UAE Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 77 UAE Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 78 Saudi Arabia Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 79 Saudi Arabia Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 80 Saudi Arabia Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 81 Saudi Arabia Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 82 Saudi Arabia Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 83 Saudi Arabia Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 84 Saudi Arabia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 85 Saudi Arabia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 86 Saudi Arabia Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 87 Saudi Arabia Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 88 Saudi Arabia Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 89 Saudi Arabia Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 90 South Africa Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 91 South Africa Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 92 South Africa Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 93 South Africa Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 94 South Africa Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 95 South Africa Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 96 South Africa Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 97 South Africa Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 98 South Africa Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 99 South Africa Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 100 South Africa Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 101 South Africa Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 102 Nigeria Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 103 Nigeria Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 104 Nigeria Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 105 Nigeria Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 106 Nigeria Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 107 Nigeria Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 108 Nigeria Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 109 Nigeria Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 110 Nigeria Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 111 Nigeria Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 112 Nigeria Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 113 Nigeria Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 114 Rest of LAMEA Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 115 Rest of LAMEA Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 116 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 117 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 118 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 119 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 120 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 121 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 122 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 123 Rest of LAMEA Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 124 Rest of LAMEA Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 125 Rest of LAMEA Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 126 Key Information – Teledyne FLIR LLC
TABLE 127 Key Information – Hikvision Digital Technology Co., Ltd.,
TABLE 128 Key Information – Axis Communications AB
TABLE 129 Key Information – Bosch Security Systems GmbH
TABLE 130 Key Information – Avigilon Corporation
TABLE 131 Key Information – Hanwha Techwin Co., Ltd.
TABLE 132 Key Information – Zhejiang Dahua Technology Co., Ltd.
TABLE 133 Key Information – Zhejiang Uniview Technologies Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, APR – 2022, Oct) Leading Players
FIG 5 Key Strategic Move: (Acquisitions and Mergers : 2018, Oct – 2022, Aug) Leading Players
FIG 6 Recent strategies and developments: Teledyne FLIR LLC
FIG 7 Swot analysis: Teledyne FLIR LLC
FIG 8 Recent strategies and developments: Hikvision Digital Technology Co., Ltd.
FIG 9 Recent strategies and developments: Axis Communications AB
FIG 10 Recent strategies and developments: Hanwha Techwin Co., Ltd.